Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer

BACKGROUND: According to previous literatures, plasma thioredoxin reductase (TrxR) level was significantly elevated in various malignant tumors and serve as a potential biomarker for diagnosis and prognostic prediction. However, there is little awareness of the clinical value of plasma TrxR in gynec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yinxing, Hu, Yixuan, Shi, Junfeng, Wei, Xiaowei, Song, Yaqi, Tang, Cuiju, Zhang, Wenwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331782/
https://www.ncbi.nlm.nih.gov/pubmed/37365925
http://dx.doi.org/10.1177/15330338231184995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331782/
https://www.ncbi.nlm.nih.gov/pubmed/37365925
http://dx.doi.org/10.1177/15330338231184995

Ejemplares similares